Precision BioSciences
DTIL
109 hedge funds and large institutions have $159M invested in Precision BioSciences in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 30 reducing their positions, and 18 closing their positions.
83% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 18
15% more funds holding
Funds holding: 95 → 109 (+14)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.13% less ownership
Funds ownership: 1.83% → 1.7% (-0.13%)
7% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 30
30% less call options, than puts
Call options by funds: $347K | Put options by funds: $498K
59% less capital invested
Capital invested by funds: $387M → $159M (-$228M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$4.89M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.3M |
| 3 |
Millennium Management
New York
|
+$1.43M |
| 4 |
JP Morgan Chase
New York
|
+$1.28M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$13M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.02M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.78M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$2.54M |
| 5 |
VP
venBio Partners
San Francisco,
California
|
-$2.24M |
DTIL Hedge Fund Activity: Q1 2020 in Review
109 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2020, worth a combined $159M — down 59% from $387M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new DTIL positions and 18 closed out — a net gain of 15 holders — while 28 added to existing stakes and 30 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $4.89M. The largest seller was AllianceBernstein, cutting an estimated $13M.
- 109 institutional investors held Precision BioSciences (DTIL) as of Q1 2020, up from 95 in Q4 2019.
- Funds reported $159M of Precision BioSciences stock for Q1 2020, down 59% quarter-over-quarter.
- 33 funds opened new Precision BioSciences positions in Q1 2020 and 18 closed out, a net change of +15 holders.
- The largest Precision BioSciences buyer in Q1 2020 was Victory Capital Management, an estimated $4.89M added.
- The largest Precision BioSciences seller in Q1 2020 was AllianceBernstein, an estimated $13M sold.
Based on aggregated 13F filings for Q1 2020.